- Drugs
- Tuesday, 17 Sep 2019
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Aphria Inc. announced that its subsidiary Marigold Projects Jamaica Limited ("Marigold") has received a retail Herb House license from Jamaica's Cannabis Licensing Authority ("CLA") to open its first store in Kingston, Jamaica.
Aphria, Inc. is engaged in the production and supply of medical cannabis. It operates through three reportable segments including cannabis operations, distribution operations, and business under development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. Aphria’s subsidiaries include Pure Natures Wellness Inc. that are engaged in the production and distribution of medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in offering support services to veterans and their first responders.
Related Industry Updates
Sutro Biopharma Adds Two Exceptional Leaders to Advisory Boards-- Carlos Paya, MD, PhD, and Lainie Martin, MD
May 22, 2020
Vaccines: A Powerful Panacea to Impound Epidemic
Aug 19, 2019
Athlete Endorsements Help Drive the CBD Industry to New Heights
Oct 25, 2019
Augmenting Cases of Chronic Diseases has increased the usage of Radiopharmaceutical
Sep 06, 2019
Christopher Hite Joins Royalty Pharma
Feb 28, 2020
North America Drug Modelling Software Market Emerging Trends and Prospects 2027 With Leading Players are Chemical Computing Group ULC, Nimbus Therapeutics, Schrödinger, Inc
Dec 30, 2020
Hikma launches Dicyclomine Hydrochloride Oral Solution
May 28, 2020